Has Roger Lyons received payments from drug or device companies?

Yes. Drug and device makers reported $2,828,266 in general payments to Roger Lyons across 1,548 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Roger Lyons did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Roger Lyons come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Roger Lyons

Hematology · San Antonio, TXNPI 1508838285

Payments from drug & device makers

$2,828,266in general payments, 2019–2025

Across 1,548 payments — averaging $1827.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Incyte Corporation$1.1M
Takeda Pharmaceuticals U.S.A., Inc.$792K
Otsuka Pharmaceutical Co., Ltd.$351K
Novartis$225K
Genentech, Inc.$146K
TG Therapeutics, Inc.$80K
plus $158K from 49 others

$73,129in research payments, 2019–2025

Across 13 payments — averaging $5625.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Takeda Pharmaceuticals U.S.A., Inc.$52K
Bristol Myers Squibb$13K
Amgen$6K
Novartis$2K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Incyte Corporation	801	$1,076,797
Takeda Pharmaceuticals U.S.A., Inc.	175	$791,792
Otsuka Pharmaceutical Co., Ltd.	81	$351,039
Novartis	29	$225,236
Genentech, Inc.	54	$145,513
TG Therapeutics, Inc.	78	$79,684
Amgen	29	$46,051
AstraZeneca(2 entities)	15	$44,000
Bristol Myers Squibb	11	$27,239
Seagen Inc.	9	$13,247
E.r. Squibb & Sons, L.L.C.	35	$10,764
Principia Biopharma Inc.	1	$3,010
UCB, Inc.	1	$2,450
Dova Pharmaceuticals	5	$2,404
Taiho Oncology, Inc.	1	$2,310
Gilead	4	$1,632
Genentech USA, Inc.	48	$561
Johnson & Johnson(2 entities)	20	$493
Sanofi	11	$404
Pfizer	26	$386
Merck	20	$357
AbbVie	8	$314
Verastem, Inc.	9	$248
Karyopharm Therapeutics Inc.	3	$176
Exelixis Inc.	5	$175
Eisai Inc.	3	$166
Astellas Pharma US Inc	12	$149
Bayer	9	$143
Rigel Pharmaceuticals, Inc.	2	$130
Genmab U.S., Inc.	1	$125
Immunogen, Inc.	1	$125
G1 Therapeutics, Inc.	1	$125
ADC Therapeutics America, Inc.	1	$122
Agios Pharmaceuticals, Inc.	1	$122
Lilly USA, LLC	3	$98
Tesaro, Inc.	1	$88
Puma Biotechnology, Inc.	5	$77
Boehringer Ingelheim	4	$61
Jazz Pharmaceuticals Inc.	3	$60
Daiichi Sankyo Inc.	3	$55
Tolmar Pharmaceuticals, Inc.	3	$42
Array Biopharma Inc	2	$33
AMAG Pharmaceuticals, Inc.	2	$32
Lexicon Pharmaceuticals, Inc.	1	$32
GSK	1	$24
EUSA Pharma (US) LLC	1	$23
Tersera Therapeutics LLC	1	$22
Apellis Pharmaceuticals, Inc.	1	$21
Stemline Therapeutics Inc.	1	$20
Sanofi-aventis U.S. LLC	1	$20
Sandoz	1	$16
Helsinn Therapeutics (U.S.), Inc.	1	$14
Alnylam Pharmaceuticals Inc.	1	$14
EMD Serono, Inc.	1	$14
Teva Pharmaceuticals USA, Inc.	1	$12

How this compares

$2,828,266 in reported general payments places this provider in the 90th percentile of 97 hematology providers in Texas.

See all hematology providers in Texas →

Other hematology in San Antonio

Montaser ShaheenSan Antonio$3.4M
Robyn ScherberSan Antonio$228K
Morgan McLemoreSan Antonio$224K
David FriedmanSan Antonio$62K
Joseph HolahanSan Antonio$5K
Swaminathan IyerHouston$10.1M
Modupe IdowuHouston$8.7M
Jing YeHouston$4.4M
Uday PopatHouston$4.4M
Sunil PatelHouston$3.5M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →